ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Features of drug-induced lupus

Features of drug-induced lupus
Key distinguishing features of drug-induced versus idiopathic lupus
Feature Drug-induced Idiopathic
Anti-dsDNA+ <5% (rare) 50 to 80%
Anti-Smith+ <5% (rare) 20 to 30%
Antihistone+ 90 to 95%* 60 to 80%
Discoid rash Rare 20%
Malar rash 2% 42%
Kidney involvement 0 to 5% 30 to 50%
Drug-specific clinical patterns
Drug Clinical features Laboratory findings
Procainamide
  • 1 to 2 months after initiation
  • Arthralgia, arthritis, myalgia, pleuritis, fever, weight loss
  • ANA in 95%
  • Antihistone antibodies
  • Anti-H2A-H2B DNA antibodies in 96%
Minocycline
  • 3 months to 6 years after initiation
  • Female:male ratio 5:1
  • Polyarthralgias, myalgias, fever, Raynaud phenomenon, mouth ulcers, hepatic damage
  • ANA in 82%
  • P-ANCA in 67%
  • Occasional anti-dsDNA
TNF-alpha inhibitors
  • 1.5 to 18 months after initiation
  • Predilection for females
  • Decreased complement
  • Cutaneous lupus erythematosus (SCLE > DLE)
  • ANA
  • Anti-dsDNA
  • Anti-Sm
  • Anticardiolipin antibodies
Terbinafine
  • 4 to 8 weeks after initiation
  • SCLE
  • ANA speckled/homogeneous pattern
  • Anti-Ro/SSA
  • Antihistone antibodies

dsDNA: double-stranded deoxyribonucleic acid; ANA: antinuclear antibody; DNA: deoxyribonucleic acid; P-ANCA: perinuclear antineutrophil cytoplasmic antibodies; TNF: tumor necrosis factor; SCLE: subacute cutaneous lupus erythematosus; DLE: discoid lupus erythematosus.

* Reported rates of antihistone antibodies with drug-induced lupus overall are 90 to 95%, but the incidence varies by agent, and lower rates have been reported for minocycline, propylthiouracil, and statins.

¶ A large proportion of patients using TNF inhibitors develop autoantibodies, but clinical signs and symptoms of a drug-induced lupus syndrome are rare.
References:
  1. Merola JF. Lupus-like syndromes related to drugs. In: Lupus Erythematosus: Clinical Evaluation and Treatment, Schur PH, Massarotti EM (Eds), Springer 2012.
  2. Rubin RL. Drug-induced lupus. Toxicology 2005; 209:135.
  3. Antonov D, Kazandjieva J, Etugov D, et al. Drug-induced lupus erythematosus. Clin Dermatol 2004; 22:157.
Graphic 69467 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟